Evidence map›Paper›PMID 35228996›Full record

ReviewJournal of orthopaedic translation2022

Periosteum and development of the tissue-engineered periosteum for guided bone regeneration.

Wentao Zhang, Naiguo Wang, Ming Yang, Tianze Sun, Jing Zhang, Yantao Zhao, Na Huo, Zhonghai Li

Open access · goldAbstract readReview
In one paragraph

Review in Journal of orthopaedic translation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed, 2 pooled it
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 2 syntheses or guidelines pooled it, 179 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Comparative Analysis of Gelatin/Polylactic Acid and Commercial PLA Membranes for Guided Bone Regeneration: A Randomized Clinical Trial.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Chondrogenic Potential of Periosteum-Derived Cells.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Wentao ZhangDepartment of Orthopedics, First Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China.
Naiguo WangDepartment of Spinal Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China.
Ming YangDepartment of Orthopedics, First Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China.
Tianze SunDepartment of Orthopedics, First Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China.
Jing ZhangDepartment of Orthopedics, First Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China.
Yantao ZhaoDepartment of Orthopedics, Fourth Medical Center of PLA General Hospital, Beijing, People's Republic of China.
Na HuoInstitute of Stomatology, First Medical Center, Chinese PLA General Hospital, Beijing, People's Republic of China.
Zhonghai LiDepartment of Orthopedics, First Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China.
Dalian Medical University · CNChinese PLA General Hospital · CNShandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPeriosteum plays a significant role in bone formation and regeneration by storing progenitor cells, and also acts as a source of local growth factors and a scaffold for recruiting cells and other growth factors. Recently, tissue-engineered periosteum has been studied extensively and shown to be important for osteogenesis and chondrogenesis. Using biomimetic methods for artificial periosteum synthesis, membranous tissues with similar function and structure to native periosteum are produced that significantly improve the efficacy of bone grafting and scaffold engineering, and can serve as direct replacements for native periosteum. Many problems involving bone defects can be solved by preparation of idealized periosteum from materials with different properties using various techniques.

methodsThis review summarizes the significance of periosteum for osteogenesis and chondrogenesis from the aspects of periosteum tissue structure, osteogenesis performance, clinical application, and development of periosteum tissue engineering. The advantages and disadvantages of different tissue engineering methods are also summarized.

resultsThe fast-developing field of periosteum tissue engineering is aimed toward synthesis of bionic periosteum that can ensure or accelerate the repair of bone defects. Artificial periosteum materials can be similar to natural periosteum in both structure and function, and have good therapeutic potential. Induction of periosteum tissue regeneration and bone regeneration by biomimetic periosteum is the ideal process for bone repair.

conclusionsPeriosteum is essential for bone formation and regeneration, and it is indispensable in bone repair. Achieving personalized structure and composition in the construction of tissue engineering periosteum is in accordance with the design concept of both universality and emphasis on individual differences and ensures the combination of commonness and individuality, which are expected to meet the clinical needs of bone repair more effectively. THE TRANSLATIONAL POTENTIAL OF THIS ARTICLE: To better understand the role of periosteum in bone repair, clarify the present research situation of periosteum and tissue engineering periosteum, and determine the development and optimization direction of tissue engineering periosteum in the future. It is hoped that periosteum tissue engineering will play a greater role in meeting the clinical needs of bone repair in the future, and makes it possible to achieve optimization of bone tissue therapy.

Indexed as

AF Antheraea pernyi fibroin, AMSCs adipose mesenchymal stem cellsBiomaterialsBMP bone morphogenetic proteins, BMP-2 bone morphogenetic protein-2BMSCs bone marrow stromal cell, CaPs calcium phosphate nanoparticles, COL I collagen IBone defect healingBone repairco-PUPCL a mixed fiber formed by PCL and polyurethane, DEX dexamethasoneDOP dopamine, DSCs dental pulp stem cellsECM extracellular matrix, GBR guided bone regenerationGelMA methacrylate gelatin, HA hydroxyapatiteHAM human amniotic membrane, HCP human cultured periosteumICA Icariin, IGF-1 insulin-like growth factor-1MBGNs mesoporous bioglass nanoparticles, MOX moxifloxacin hydrochlorideMSCs mesenchymal stem cells, n-HA nano-hydroxyapatiteOCN osteocalcin, OSX osterixOsteogenesisPCL polycaprolactone, PDCs periosteum derived cellsPDGF-BB platelet-derived growth factor-BB, PDO periosteal distraction osteogenesisPEEK polyetheretherketone, PLA polylactic acidPeriosteumPLLA l-lactic acid, PRP platelet-rich plasmaPU degradable polyurethane fibers without nano-hydroxyapatite, PUHA degradable polyurethane fibers with nano-hydroxyapatitePVA polyvinyl alcohol, rhBMP-2 recombinant human bone morphogenetic protein-2rMSCs rat mesenchymal stem cells, Runx2 Runt-related transcription factor 2SEM scanning electron microscope, SF silk fibroinSiNPs Silica nanoparticles, SIS small intestinal submucosas-PEEK sulfonated PEEK, SSCs skeletal stem cellsSSP synthetic scaffold periosteum, TCP tricalcium phosphateTGF-β transforming growth factor-β, VEGF vascular endothelial growth factorsTissue-engineered periosteum

Identifiers

PMID35228996
PMCPMC8858911
OpenAlexW4213365620

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.